Prognostic Factors in Lung Cancer

  • Frank B. Zimmermann
Part of the Medical Radiology Radiation Oncology book series (MEDRAD)


Lung Cancer Clin Oncol Small Cell Lung Cancer Radiat Oncol Biol Phys Karnofsky Performance Status 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Albain KS, Crowley JJ, Leblanc M, Livingston RB (1990) Determinants of improved outcome in small-cell lung cancer: an analysis of the 2580-patient Southwest Oncology Group data base. J Clin Oncol 8:1563–1574Google Scholar
  2. Bergh JC (1990) Gene amplification in human lung cancer: the myc family genes and other proto-oncogenes and growth factor genes. Am Rev Respir Dis 142:S20–S26PubMedGoogle Scholar
  3. Brambilla E, Travis WD, Colby TV et al (2001) The new World Health Organization classification of lung tumours. Eur Respir J 18:1059–1068PubMedGoogle Scholar
  4. Brechot JM, Chevret S, Charpentier MC et al (1996) Blood vessel and lymphatic vesel invasion in resected nonsmall cell lung carcinoma: correlation with TNM stage and disease free and overall survival. Cancer 78:2111–2118CrossRefPubMedGoogle Scholar
  5. Bremnes RM, Sundstrom S, Aasebo U et al (2003) The value of prognostic factors in small cell lung cancer: results from a randomized multicenter study with minimum 5 year follow-up. Lung Cancer 39:303–313CrossRefPubMedGoogle Scholar
  6. Brundage MD, Feldman-Stewart D, Cosby R et al (2001) Phase I study of a decision aid for patients with locally advanced non-small cell lung cancer. J Clin Oncol 19:1326–1335PubMedGoogle Scholar
  7. Brundage MD, Davies D, Mackillop WJ (2002) Prognostic factors in non-small cell lung cancer. Chest 122:1037–1057CrossRefPubMedGoogle Scholar
  8. Buccheri G (1998) Depressive reactions to lung cancer are common and often followed by a poor outcome. Eur Respir J 11:173–178CrossRefPubMedGoogle Scholar
  9. Buccheri G, Ferrigno D (1994) Prognostic factors in lung cancer: tables and comments. Eur Respir J 7:1350–1364CrossRefPubMedGoogle Scholar
  10. Buccheri G, Ferrigno D (2004) Prognostic factors. Hematol Oncol Clin N Am 18:187–201CrossRefGoogle Scholar
  11. Buccheri G, Ferrigno D, Tamburini M (1996) Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer 32A:1135–1141PubMedGoogle Scholar
  12. Choi N, Baumann M, Flentje M et al (2001) Predictive factors in radiotherapy for non-small cell lung cancer: present status. Lung Cancer 31:43–56CrossRefPubMedGoogle Scholar
  13. Detterbeck FC (1997) Pancoast (superior sulcus) tumors. Ann Thorac Surg 63:1810–1818PubMedGoogle Scholar
  14. Emami B, Perez CA (1993) Lung. In: Perez CA (ed) Radiation oncology. Lippincott, PhiladelphiaGoogle Scholar
  15. Feld R, Borges M, Giner V et al (1994) Prognostic factors in non-small cell lung cancer. Lung Cancer 11[Suppl]:S19–S23CrossRefPubMedGoogle Scholar
  16. Ferrigno D, Buccheri D, Biggi A (1994) Serum tumour markers in lung cancer: history, biology and clinical applications. Eur Respir J 7:186–197CrossRefPubMedGoogle Scholar
  17. Fontanini G, Lucchi M, Vignati S et al (1997) Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study. J Natl Cancer Inst 89:881–886PubMedGoogle Scholar
  18. Fontanini G, De Laurentiis M, Vignati S et al (1998) Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival. Clin Cancer Res 4:241–249PubMedGoogle Scholar
  19. Ginsberg RJ, Vokes EE, Raben A (1999) Cancer of the lung. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology. Lippincott-Raven, Philadelphia, pp 849–950Google Scholar
  20. Graziano SL (1997) Non-small cell lung cancer: clinical value of new biological predictors. Lung Cancer 17:S37CrossRefPubMedGoogle Scholar
  21. Harpole DH, Herndone JE, Young WG et al (1995) Stage I non-small cell lung cancer: a multivariate analysis of treatment methods and patterns of recurrence. Cancer 76:787PubMedGoogle Scholar
  22. Hespanhol V, Queiroga H, Magalhaes A et al (1995) Survival predictors in advanced non-small cell lung cancer. Lung Cancer 13:253–267CrossRefPubMedGoogle Scholar
  23. Hirsch FR, Matthews MJ, Aisner S, et al (1988) Histopathologic classification of small cell lung cancer. Changing concepts and terminology. Cancer 62:973–977PubMedGoogle Scholar
  24. Iyengar P, Tsao MS (2002) Clinical relevance of molecular markers in lung cancer. Surg Oncol 11:167–179CrossRefPubMedGoogle Scholar
  25. Jassem E, Bigda J, Dziadziuszko R et al (2001) Serum p53 antibodies in small cell lung cancer: the lack of prognostic relevance. Lung Cancer 31:17–23CrossRefPubMedGoogle Scholar
  26. Jazieh AR, Hussain M, Howington JA et al (2000) Prognostic factors in patients with surgically resected stages I and II non-small cell lung cancer. Ann Thorac Surg 70:1168CrossRefPubMedGoogle Scholar
  27. Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic (1997) Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study. J Clin Oncol 15:893–900PubMedGoogle Scholar
  28. Jeremic B, Shibamoto Y, Nikoloic N et al (1999) Role of Radiation Therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: a randomized study. J Clin Oncol 17:2092–2099PubMedGoogle Scholar
  29. Jeremic B, Classen J, Bamberg M (2002) Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non-small cell lung cancer. Int J Radiat Oncol Biol Phys 54:119–130CrossRefPubMedGoogle Scholar
  30. Jorgensen LG, Osterlind K, Genollá J et al (1996) Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariate analysis on data from nine centres. Br J Cancer 74:463–467PubMedGoogle Scholar
  31. Kessler R, Gasser B, Massard G et al (1996) Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer. Ann Thorac Surg 62:1489–1493CrossRefPubMedGoogle Scholar
  32. Kwiatkowski DJ, Harpole DH Jr, Godleski J et al (1998) Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications: J Clin Oncol 16:2468–2477PubMedGoogle Scholar
  33. Lad T, Piaritadosi S, Thomas P et al (1994) A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small-cell lung cancer to combination chemotherapy. Chest 106:3205–3235Google Scholar
  34. Lamy P, Grenier J, Kramar A, Pujol J (2000) Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer. Lung Cancer 29:197–203CrossRefPubMedGoogle Scholar
  35. Langendijk H, Aaronson NK, de Jong JM et al (2000) The prognostic impact of quality of life assessed with the EORCT QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol 55:19–25CrossRefPubMedGoogle Scholar
  36. Lebeau B, Chastang C, Schuller MP et al (1995) Chimiothérapie des cancers bronchiques: importance prognostique d'une résponse complète (1280 patients). La Presse Médicale 24:217–221PubMedGoogle Scholar
  37. Lebeau B, Urban T, Brechot JM et al (1999) A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small-cell lung cancer. Cancer 86:1480–1487CrossRefPubMedGoogle Scholar
  38. Lee JH, Machtay M, Kaiser LR et al (1999) Non-small cell lung cancer: prognostic factors in patients treated with surgery and postoperative radiation therapy. Radiology 213:845–852PubMedGoogle Scholar
  39. MacKillop WJ (2001) The importance of prognosis in cancer medicine. In: Gospodarowicz MK, Henson DE, Hutter RBP et al (eds) Prognostic factors in cancer. Wiley, New YorkGoogle Scholar
  40. Meert AP, Paesmans M, Martin B et al (2002) The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer 87:694–701CrossRefPubMedGoogle Scholar
  41. Micke P, Faldum A, Metz T et al (2002) Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer — what limits limited disease? Lung Cancer 37:271–276CrossRefPubMedGoogle Scholar
  42. Montazeri A, Milroy R, Hole D et al (2001) Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer 31:233–240CrossRefPubMedGoogle Scholar
  43. Mori M, Kohli A, Baker SP et al (1997) Laminin and cathepsin B as prognostic factors in stage I non-small cell lung cancer: are they useful? Mod Pathol 10:572–577PubMedGoogle Scholar
  44. Mountain, CF (1997) Revisions in the International System for Staging Lung Cancer. Chest 111:1710–1717PubMedGoogle Scholar
  45. Murray N, Coy P, Pater JL et al (1993) Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. J Clin Oncol 11:336–344PubMedGoogle Scholar
  46. Murray PV, Soussi T, O'Brian ME et al (2000) Serum p53 antibodies: predictors of survival in small-cell lung cancer? Br J Cancer 83:1418–1424CrossRefPubMedGoogle Scholar
  47. Naughton MJ, Herndon JE, Shumaker SA et al (2002) The health-related quality of life and survival of small-cell lung cancer patients: results of a companion study of CALGB 9033. Qual Life Res 11:235–248CrossRefPubMedGoogle Scholar
  48. Paesmans M (2004) Prognosis of small cell lung cancer. In: Sculier JP, Fray WA (eds) Malignant tumors of the lung. Springer, Berlin Heidelberg New York, pp 423–432Google Scholar
  49. Paesmans M, Sculier JP, Libert P et al (1995) Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients: the European Lung Cancer Working Party. J Clin Oncol 13:1221–1230PubMedGoogle Scholar
  50. Paesmans M, Sculier JP, Lecomte J et al (2000) Prognostic factors for patients with small cell lung cancer. Cancer 89:523–533CrossRefPubMedGoogle Scholar
  51. Palomares MR, Sayre JW, Shekar KC et al (1996) Gender influence on weight-loss pattern and survival of non-small cell lung carcinoma patients. Cancer 78:2119–2126CrossRefPubMedGoogle Scholar
  52. Pedersen LM, Milman N (1996) Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Resp J 9:1826–1830CrossRefGoogle Scholar
  53. Picardo AL, Diez M, Torres A et al (1996) Analysis of the prognostic significance of cytosolic determination of CA 125, CEA, and SCC in patients with NSCLC. Cancer 77:1066–1072CrossRefPubMedGoogle Scholar
  54. Pujol JL, Quantin X, Jacot W et al (2003) Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer. Lung Cancer 39:131–138CrossRefPubMedGoogle Scholar
  55. Quejada MI, Albain KS (2004) Prognostic factors in non-small cell lung cancer. In: Sculier JP, Fry WA (eds) Malignant tumors of the lung. Springer, Berlin Heidelberg New York, pp 405–422Google Scholar
  56. Quoix E, Purohit A, Faller-Beau M et al (2000) Comparative prognostic value of lactate dehydrogenase and neuron-specific enolase in small-cell lung cancer patients treated with platinum-based chemotherapy. Lung Cancer 30:127–134PubMedGoogle Scholar
  57. Rawson NSB, Peto J (1990) An overview of prognostic factors in small cell lung cancer: a report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research. Br J Cancer 61:597–604PubMedGoogle Scholar
  58. Ray R, Quantin X, Grenier J, Pujol JL (1998) Predictive factors of tumor response and prognostic factors of survival during lung cancer chemotherapy. Cancer Detect Prey 22:293–304CrossRefGoogle Scholar
  59. Rygaard K, Vindelov LL, Spang-Thomsen M (1993) Expression of myc family oncoproteins in small-cell lung-cancer cell lines and xenografts. Int J Cancer 54:144–152PubMedGoogle Scholar
  60. Sabiston DCJ, Spencer FC (1995) Surgery of the chest. Saunders, PhiladelphiaGoogle Scholar
  61. Salgia R, Skarin AT (1998) Molecular abnormalities in lung cancer. J Clin Oncol 16:1207–1217PubMedGoogle Scholar
  62. Saunders M, Dische S, Barrett A et al (1999) Continuous hyper-fractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomized multicentre trial. Radiother Oncol 52:137–148CrossRefPubMedGoogle Scholar
  63. Sause W (2001) Nonsurgical management of non-small-cell lung cancer. Hem Oncol Clin N Am 5:277–289CrossRefGoogle Scholar
  64. Sheperd FA, Ginsberg R, Patterson GA et al (1991) Surgical treatment for limited small-cell lung cancer. J Cardiovasc Surg 101:385–393Google Scholar
  65. Stanley KE (1980) Prognostic factors for survival in patients with inoperable lung cancer. J Natl Cancer Inst 65:25–32PubMedGoogle Scholar
  66. Stewart LA, Pignon JP (1995) Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311:899–909PubMedGoogle Scholar
  67. Sunaga N, Tsuchiya S, Minato K et al (1999) Serum pro-gastrin-releasing peptide is a useful marker for treatment monitoring and survival in small-cell lung cancer. Oncology 57:143–148CrossRefPubMedGoogle Scholar
  68. Takada M, Fukuoka M, Kawahara M et al (2002) Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small cell lung cancer: results of the Japan Clinical Oncology Group study 9104. J Clin Oncol 20:3054–3060CrossRefPubMedGoogle Scholar
  69. Takigawa N, Segawa Y, Okahara M et al (1996) Prognostic factors for patients with advanced non-small cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation. Lung Cancer 15:67–77CrossRefPubMedGoogle Scholar
  70. Tamura M, Ueoka H, Kiura K et al (1998) Prognostic factors of small-cell lung cancer in Okayama Lung Cancer Study Group Trials. Acta Med Okayama 52:105–111PubMedGoogle Scholar
  71. Turrisi AT, Kim K, Blum R et al (1999) Twice-daily compared with one-daily thoracic radiotherapy in limited small cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340:265–271Google Scholar
  72. Vansteenkiste J, Buccheri G, Carney D et al (2002) Prognostic factors in nonsmall cell lung cancer. Eur Respir Rev 12:84:156–171Google Scholar
  73. Warde P, Payne D (1992) Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 10:890–895PubMedGoogle Scholar
  74. Wigren T, Oksanen H, Kellokumpu-Lehtinen P (1997) A practical prognostic index for inoperable non-small-cell lung cancer. J Cancer Res Clin Oncol 123:259–266PubMedGoogle Scholar
  75. Willner J, Baier K, Caragiani E et al (2002) Dose, volume, and tumor control predictions in primary radiotherapy of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 52:382–389CrossRefPubMedGoogle Scholar
  76. Wolf M, Holle R, Hans K et al (1991) Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): the role of sex as a predictor for survival. Br J Cancer 63:986–992PubMedGoogle Scholar
  77. Work E, Nielson OS, Bentzen SM et al (1997) Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. J Clin Oncol 15:3030–3037PubMedGoogle Scholar
  78. Würschmidt F, Bünemann H, Heilmann HP (1995) Small cell lung cancer with and without vena cava syndrome: a multivariate analysis of prognostic factors in 408 cases. Int J Radiat Oncol Biol Phys 33:77–82CrossRefPubMedGoogle Scholar
  79. Yip D, Harper PG (2000) Predictive and prognostic factors in small cell lung cancer: current status. Lung Cancer 28:173–185CrossRefPubMedGoogle Scholar
  80. Zimmermann FB, Bamberg M, Molls M, Jeremic B (2003a) Limited-disease small-cell lung cancer. Sem Surg Oncol 21:156–163CrossRefGoogle Scholar
  81. Zimmermann FB, Bamberg M, Molls M, Jeremic B (2003b) Radiation therapy alone in early stage non-small-cell lung cancer. Semin Surg Oncol 21:91–97CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Frank B. Zimmermann
    • 1
  1. 1.Department of Radiation Oncology, Klinikum rechts der IsarTechnical University MunichMunichGermany

Personalised recommendations